BioSpace News Archive

The report highlights trends prevailing in the market, and the factors driving and hindering the market growth.

The report highlights trends prevailing in the market, and the factors driving and hindering the market growth.

It is estimated to grow at a CAGR of 11.2% from 2020 to 2027.

The report highlights the trends prevalent in the global patient flow management market and the factors driving the market along with those that act as deterrents to its growth.

Sharps Compliance Corp. (Nasdaq: SMED) announced today that David P. Tusa, President and Chief Executive Officer, will participate in the ROTH Virtual London Conference on Tuesday, June 22, 2021.

Of the 700 physicians responding to an internet survey by the Association of American Physicians and Surgeons, nearly 60 percent said they were not “fully vaccinated” against COVID.

Cure Network Dolby Acceleration Partners LLC and Takeda Pharmaceutical Company Limited have entered into a research collaboration to develop small molecules targeting tau, a protein involved in Alzheimer’s disease and other major brain disorders.

The American Diabetes Association® issued important updates to the 2021 Standards of Medical Care in Diabetes, in annotations as the Living Standards of Care.

SALT LAKE CITY, June 16, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that it has named Thomas P. Slavin Jr. (T.J.), M.D., FACMG, DABMD, chief medical officer of the company. He will report directly to Nicole Lambert, president of Myriad Genetic Laboratories. In his new role, Dr. Slavin will apply deep clinical and scientific expertise, combined with proven leadership and experience in precision medicine, t

Novan, Inc. (the “Company” or “Novan”) (NASDAQ: NOVN) today announced a proposed underwritten public offering of its common stock (the “Offering”).